Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 140,622 7.500% | -6,478 (-4.40%) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT | SUVRETTA CAPITAL MANAGEMENT, LLC | 111,513 6.000% | 111,513 (New Position) | Filing History |
| 2021-11-22 4:03 pm Unchanged | 2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 225,200 12.000% | 0 (Unchanged) | Filing History |
| 2021-08-13 5:02 pm Purchase | 2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I, L.P. | 152,921 8.400% | 58,348 (+61.70%) | Filing History |
| 2021-04-07 4:30 pm Purchase | 2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA CAPITAL MANAGEMENT L.P. | 118,916 6.500% | 118,916 (New Position) | Filing History |